Search results for "Thienamycin"

showing 5 items of 5 documents

Parietal subdural empyema as complication of acute odontogenic sinusitis: a case report

2014

Introduction: To date intracranial complication caused by tooth extractions are extremely rare. In particular parietal subdural empyema of odontogenic origin has not been described. A literature review is presented here to emphasize the extreme rarity of this clinical entity. Case presentation: An 18-year-old Caucasian man with a history of dental extraction developed dysarthria, lethargy, purulent rhinorrhea, and fever. A computed tomography scan demonstrated extensive sinusitis involving maxillary sinus, anterior ethmoid and frontal sinus on the left side and a subdural fluid collection in the temporal-parietal site on the same side. He underwent vancomycin, metronidazole and meropenem th…

Malemedicine.medical_specialtyAdolescentMaxillary sinusmedicine.medical_treatmentCase ReportSubdural empyemaSubdural SpaceDiagnosis DifferentialIntracranial infections Odontogenic sinusitis Paranasal sinusitis Subdural empyemaVancomycinMetronidazoleParietal LobemedicineHumansSinusitisSubdural spaceSinusitisCraniotomyOdontogenic sinusitisSubdural empyemaMedicine(all)Empyema SubduralFrontal sinusrhinorrheabusiness.industryParanasal sinusitisSettore MED/37 - NeuroradiologiaSequelaMeropenemGeneral MedicineMaxillary Sinusmedicine.diseaseAnti-Bacterial AgentsSurgerySettore MED/32 - AudiologiaTreatment Outcomemedicine.anatomical_structureSettore MED/31 - OtorinolaringoiatriaIntracranial infectionsAcute DiseaseTooth ExtractionThienamycinsmedicine.symptomTomography X-Ray ComputedbusinessCraniotomyFollow-Up Studies
researchProduct

Enterococcal meningitis caused by Enterococcus casseliflavus. First case report

2005

Abstract Background Enterococcal meningitis is an uncommon disease usually caused by Enterococcus faecalis and Enterococcus faecium and is associated with a high mortality rate. Enterococcus casseliflavus has been implicated in a wide variety of infections in humans, but never in meningitis. Case presentation A 77-year-old Italian female presented for evaluation of fever, stupor, diarrhea and vomiting of 3 days duration. There was no history of head injury nor of previous surgical procedures. She had been suffering from rheumatoid arthritis for 30 years, for which she was being treated with steroids and methotrexate. On admission, she was febrile, alert but not oriented to time and place. H…

BACTEREMIACase ReportMicrobial Sensitivity TestsVANCOMYCIN-RESISTANT ENTEROCOCCI; CLINICAL-FEATURES; BACTEREMIA; GALLINARUM; MOTILE ENTEROCOCCUS; OUTCOMESMeropenemEnterococcus faecalisVANCOMYCIN-RESISTANT ENTEROCOCCIlcsh:Infectious and parasitic diseaseslaw.inventionMicrobiologyMeningitis BacteriallawAmpicillinmedicineEnterococcus casseliflavusHumanslcsh:RC109-216Gram-Positive Bacterial InfectionsAgedCerebrospinal FluidOUTCOMESSigmoid Diseasesbiologybusiness.industryCLINICAL-FEATURESMeropenembiochemical phenomena metabolism and nutritionbiology.organism_classificationmedicine.diseaseAnti-Bacterial AgentsMOTILE ENTEROCOCCUSInfectious DiseasesGram stainingEnterococcusSulbactamGALLINARUMAmpicillinFemaleThienamycinsbusinessMeningitisEnterococcusmedicine.drugEnterococcus faeciumBMC Infectious Diseases
researchProduct

Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic an…

2016

Objectives: We utilized the database of the Defining Antibiotic Levels in Intensive care unit patients (DALI) study to statistically compare the pharmacokinetic/pharmacodynamic and clinical outcomes between prolonged- infusion and intermittent-bolus dosing of piperacillin/tazobactam and meropenem in critically ill patients using inclusion criteria similar to those used in previous prospective studies. Methods: This was a post hoc analysis of a prospective, multicentre pharmacokinetic point-prevalence study (DALI), which recruited a large cohort of critically ill patients from 68 ICUs across 10 countries. Results: Of the 211 patients receiving piperacillin/tazobactam and meropenem in the DAL…

0301 basic medicineMalePenicillanic Acidintensive care unitlaw.inventionthienamycin derivative abdominal infection[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseaseslawcentral nervous system infectioncreatinine clearancePharmacology (medical)Infusions IntravenouProspective StudiesInfusions IntravenousProspective cohort studyTazobactam Drug CombinationAged; Anti-Bacterial Agents; Blood Chemical Analysis; Critical Illness; Female; Humans; Infusions Intravenous; Intensive Care Units; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin Tazobactam Drug Combination; Prospective Studies; Thienamycins; Treatment Outcome; Pharmacology; Microbiology (medical); Pharmacology (medical); Infectious Diseasescritical illneMicrobial Sensitivity TestadultRespiratory infectionclinical trialMiddle Agedcontinuous infusionanalogs and derivativeIntensive care unit3. Good healthAnti-Bacterial Agentsantiinfective agentintravenous drug administrationIntensive Care Units[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyTreatment OutcomeInfectious DiseasesPiperacillin/tazobactammulticenter study (topic)SOFA scoreFemaletreatment outcome AgedIntravenousprospective studyHumanmedicine.drugsurvival rateMicrobiology (medical)medicine.medical_specialtyInfusionspost hoc analysirespiratory tract infectionCritical IllnessAged; Anti-Bacterial Agents; Blood Chemical Analysis; Critical Illness; Female; Humans; Infusions Intravenous; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Thienamycins; Treatment Outcome; Pharmacology; Pharmacology (medical); Infectious Diseases030106 microbiologybloodstream infectionMicrobial Sensitivity Testsminimum inhibitory concentrationpiperacillin plus tazobactamMeropenemTazobactamArticle03 medical and health sciencescritically ill patientInternal medicineAnti-Bacterial AgentmedicineSequential Organ Failure Assessment ScoreHumansThienamycinsurvival timeblood analysiAgedPiperacillinPharmacologybusiness.industryBlood Chemical AnalysiMeropenemmajor clinical studySurgeryProspective Studiemulticenter studyPharmacology; Pharmacology (medical); Infectious Diseases[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologyThienamycinspiperacillin tazobactam drug combinationurinary tract infectionbusinessBlood Chemical AnalysisPiperacillin
researchProduct

Determination of meropenem in endotracheal tubes by in-tube solid phase microextraction coupled to capillary liquid chromatography with diode array d…

2017

Meropenem is a widely used antimicrobial for the treatment of infections associated with the use of invasive medical devices in intensive care unit patients. These treatments are not always effective, in fact, in-vitro studies have demonstrated the difficulty of antimicrobials to penetrate into the biofilm, however in-vivo studies of the effect of these compounds is a trend, mostly because of the complexity of pulmonary samples extracted from ETTs. Therefore, the objective of this study was to evaluate in-tube solid phase microextraction (in-tube SPME) coupled to capillary liquid chromatography (CapLC) with DAD to determine meropenem in Errs in order to estimate the penetration capability i…

0301 basic medicineCapillary action030106 microbiologyClinical BiochemistryPharmaceutical ScienceEndotracheal tubesengineering.materialSolid-phase microextraction01 natural sciencesMeropenemAnalytical Chemistry03 medical and health sciencesCapillary columnCoatingCapillary ElectrochromatographyLimit of DetectionCapillary-LC-DADDrug DiscoverymedicineIntubation IntratrachealHumansSpectroscopySolid Phase MicroextractionChromatographyChemistryBiofilm010401 analytical chemistryIn-tube SPMEPenetration (firestop)MeropenemDiode array0104 chemical sciencesAnti-Bacterial AgentsCapillary lengthengineeringThienamycinsmedicine.drugChromatography LiquidJournal of pharmaceutical and biomedical analysis
researchProduct

Susceptibility of Pseudomonas aeruginosa isolates to ceftazidime is unrelated to the expression of the outer membrane protein OprC.

1997

Previously, it has been postulated that the porin OprC facilitates the diffusion of ceftazidime through the outer membrane of Pseudomonas aeruginosa. To further investigate this claim, the outer membrane protein (OMP) profiles of 22 ceftazidime-susceptible clinical isolates were analyzed. No correlation was found between MIC values and the level of expression of OprC. Further, OprC was either undetectable or expressed in reduced amounts in 12 isolates. In contrast, OprF and OprE were present in all isolates studied. This study suggests that OprC is dispensable for the permeation of ceftazidime through the outer membrane of P. aeruginosa.

CeftazidimePorinsmedicine.disease_causePorinaCeftazidimeMicrobiologyBacterial ProteinsDrug DiscoverymedicineHumansPharmacology (medical)Antibacterial agentPharmacologybiologyPseudomonas aeruginosaGeneral Medicinebiology.organism_classificationCephalosporinsImipenemInfectious DiseasesOncologyMembrane proteinSpainPorinPseudomonas aeruginosaThienamycinsBacterial outer membranePseudomonadaceaemedicine.drugBacterial Outer Membrane ProteinsChemotherapy
researchProduct